VRTX
47
-6
V
64
-2
JNPR
50
-6
SNA
70
-5
AIZ
82
2
INTU
58
-3
WHR
65
-5
SRE
63
2
MRK
17
-5
AMGN
42
-4
GOOG
57
-6
CMG
66
-4
PBI
56
-2
BXP
49
-3
LLY
28
-8
LRCX
37
-9
SWK
50
-5
KIM
72
2
MDLZ
32
-4
ZBH
65
3
VRTX
47
-6
V
64
-2
JNPR
50
-6
SNA
70
-5
AIZ
82
2
INTU
58
-3
WHR
65
-5
SRE
63
2
MRK
17
-5
AMGN
42
-4
GOOG
57
-6
CMG
66
-4
PBI
56
-2
BXP
49
-3
LLY
28
-8
LRCX
37
-9
SWK
50
-5
KIM
72
2
MDLZ
32
-4
ZBH
65
3
Financhill
Back

UBS ETRACS Alerian MLPInfrs ETN SerB Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
81

MLPB
UBS ETRACS Alerian MLPInfrs ETN SerB

Last Price:
24.67
Seasonality Move:
6.23%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
81
UBS ETRACS Alerian MLPInfrs ETN SerB (MLPB) is a Buy

Is UBS ETRACS Alerian MLPInfrs ETN SerB a Buy, Sell or Hold?

  • The current UBS ETRACS Alerian MLPInfrs ETN SerB [MLPB] share price is $24.96. The Score for MLPB is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
  • MLPB is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MLPB Stock Price Chart

What is UBS ETRACS Alerian MLPInfrs ETN SerB's stock price today?

  • The UBS ETRACS Alerian MLPInfrs ETN SerB share price today is $24.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLPB is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

MLPB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 66.22 Buy
Chaikin Money Flow: 15156 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.69 - 24.51) Buy
Bollinger Bands (100): (23.79 - 24.71) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

MLPB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.64 Buy
20-day SMA: 24.11 Buy
50-day SMA: 24.25 Buy
200-day SMA: 23.86 Buy
8-day EMA: 24.55 Buy
20-day EMA: 24.31 Buy
50-day EMA: 24.21 Buy
200-day EMA: 23.6 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

UBS ETRACS Alerian MLPInfrs ETN SerB Earnings Growth & MLPB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

UBS ETRACS Alerian MLPInfrs ETN SerB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):